Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Clinical trial NCT06696833 · RECRUITING
Trial details
- NCT number
- NCT06696833
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.